The metastatic incidence of retroperitoneal dedifferentiated liposarcoma is comparatively lower than other pleomorphic sarcomas, varying widely from 1 to 18%. Low-grade dedifferentiation resembling ...

Liposarcomas are a rare type of malignancy with a very heterogeneous morphological appearance and clinical course. The therapeutic approach is based on histopathological classification and is ...

We identified 276 patients with primary retroperitoneal WDLS and 353 patients with primary retroperitoneal DDLS who underwent resection between July 1982 and July 2021 at our institution. WDLS ...

nab-Sirolimus for patients with advanced malignant PEComa with or without prior mTOR inhibitors: Biomarker results from AMPECT and an expanded access program. Genetic abnormalities and aberrant ...

Please provide your email address to receive an email when new articles are posted on . Milademetan failed to significantly extend PFS among patients with dedifferentiated liposarcoma, according to ...

MD Anderson-led Phase II trial suggests neoadjuvant immunotherapy is safe and may be an effective option for patients with soft-tissue sarcomas After treatment with a combination of immunotherapy and ...

High TMB and TAM density may predict positive ICI response in DDLPS patients, as shown in a case with pembrolizumab achieving pCR. The patient, initially treated with doxorubicin, pazopanib, and ...

Please provide your email address to receive an email when new articles are posted on . A phase 2 trial conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated the ...

Liposarcoma is a rare cancer of connective tissues that resemble fat cells under a microscope. Dedifferentiated liposarcoma (DDLS) is a high-grade subtype of liposarcoma that progresses from ...

Jackie Garcia from Houston experienced misdiagnoses and weight gain. Doctors initially prescribed weight loss methods. Later, a CT scan revealed retroperitoneal liposarcoma. The tumor weighed nine ...